Ventas, Inc. – Consensus ‘buy’ rating and 9.4% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Ventas, Inc. which can be found using ticker (VTR) now have 17 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $60.00 and $47.00 suggesting an average Analsyt target price of $52.59. Given that the stocks previous close was at $48.05 and the analysts are correct then there would likely be a percentage uptick in value of 9.4%. There is a 50 day moving average of $47.18 and the 200 day moving average is $45.31. The company has a market cap of 19.49B. The stock price for the company is currently $48.44 USD

The potential market cap would be $21,332,971,127 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 2422, revenue per share of $10.87 and a 1.58% return on assets.

Ventas, Inc. is a real estate investment trust (REIT). The Company is engaged in operating at the intersection of healthcare and real estate. It has a portfolio of senior housing communities, medical office buildings (MOBs), life science, research and innovation centers, hospitals and other healthcare facilities. The Company’s segments include Triple-Net Leased Properties, Senior Housing Operating Portfolio (SHOP), and Office Operations. Triple-Net Leased Properties is engaged in investing in and owning senior housing and healthcare properties throughout the United States and the United Kingdom and leasing those properties to healthcare operating companies under triple-net or absolute-net leases. The Senior Housing Operating Portfolio (SHOP) segment invests in senior housing communities throughout the United States and Canada. The Office Operations segment acquires, owns, develops, leases and manages MOBs and life science, research and innovation centers throughout the United States.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search